Average Co-Inventor Count = 10.78
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (13 from 2,405 patents)
2. Merck + Co., Inc. (3 from 4,770 patents)
3. Merck Canada Inc. (1 from 40 patents)
16 patents:
1. 10208060 - Inhibitors of HIF prolyl hydroxylase
2. 10000501 - Inhibitors of HIF prolyl hydroxylase
3. 9969752 - Inhibitors of HIF prolyl hydroxylase
4. 9745295 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
5. 9499534 - Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
6. 9120785 - Pyridyl aminopyridines as Syk inhibitors
7. 9018224 - Substituted cyclopropyl compounds useful as GPR119 agonists
8. 8957062 - Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
9. 8653260 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10. 8501786 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
11. 8399480 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
12. 8354403 - Pyrrolidine derived beta 3 adrenergic receptor agonists
13. 8247415 - Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists
14. 7388019 - 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
15. 6476054 - Cyclic amine modulators of chemokine receptor activity